Leissner, P., Verjat, T., Bachelot, T., Paye, M., Krause, A., Puisieux, A., & Mougin, B. (2006). Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer. BioMed Central.
Chicago Style CitationLeissner, Philippe, Thibault Verjat, Thomas Bachelot, Malick Paye, Alexander Krause, Alain Puisieux, i Bruno Mougin. Prognostic Significance of Urokinase Plasminogen Activator and Plasminogen Activator Inhibitor-1 MRNA Expression in Lymph Node- and Hormone Receptor-positive Breast Cancer. BioMed Central, 2006.
Cita MLALeissner, Philippe, et al. Prognostic Significance of Urokinase Plasminogen Activator and Plasminogen Activator Inhibitor-1 MRNA Expression in Lymph Node- and Hormone Receptor-positive Breast Cancer. BioMed Central, 2006.